RNAC 8-K 2026-01-09

Cartesian Therapeutics, Inc. (RNAC) 8-K dated 2026-01-09 — accession 0001453687-26-000051. This URL is the filing, not the RNAC hub.

Cartesian Therapeutics, Inc. (RNAC) is a biotechnology company listed on US.

Cartesian Therapeutics, Inc. filed a 8-K on 2026-01-09. Accession 0001453687-26-000051.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RNAC revenue for 2026-06-30 was $78.0K. Net income was -$23.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.

Not investment advice. The RNAC SEC hub lists recent forms. The stock page is the research view.